Atlas Antibodies Presents QPrEST Standards for Absolute Quantification of Proteins using Mass Spectrometry

Atlas Antibodies AB, a leading supplier of advanced research reagents, announced today the introduction of pre-quantified QPrEST™ Protein Standards for absolute quantification of proteins in biological samples such as cell lysate and plasma using liquid chromatography (LC)–mass spectrometry (MS).

Atlas Antibodies
Sep 17, 2019

QPrESTs consists of 50-150 amino acids identical to a part of the corresponding human protein. They are produced recombinantly in the presence of stable isotope-labeled (i.e. heavy) amino acids to generate protein standards. Targeted proteomics is a method allowing absolute quantification of the proteins of interest by comparing the MS signal intensities of the stable isotope standard with an endogenous peptide that is generated upon proteolytic digestion of the target protein.

One of the advantages of QPrESTs over other available protein standards is that they are added to the sample early in the workflow, prior to proteolytic digestion. The shared amino acid sequence of the QPrEST and the endogenous protein enables the QPrEST to correct for variation introduced during sample digestion, thereby increasing accuracy in quantification.

John Daicic, CEO of Atlas Antibodies, commented: “Just like our antibodies, the new, pre-quantified QPrEST standards are available for the vast majority of the proteins in the human proteome. It is essential that our product portfolio expands to address additional needs from our customers, and targeted proteomics is an expanding field with great potential. We will continue building on our heritage from the Human Protein Atlas  by adding to our antibody portfolio as well as increasing our offering for proteomics research.”

QPrEST products are being showcased at Atlas Antibodies’ booth #12 at the ongoing HUPO World Congress in Adelaide, Australia.

May 2020

Making Memories

The fundamental cognitive process is revealing itself to science


Sponsored Product Updates

NanoString and OnRamp BioInformatics Partner to Develop Cloud-Based Analysis Solutions for nCounter Data
Expanded Functionality to Support COVID-19 Research Immediately Available Through Early Access 
Optimizing Live Cell Monitoring
Download this white paper to learn how to optimize live cell monitoring workflows for advanced cell models
Troubleshooting Water Problems in Laboratory Experiments
Download this guide to learn tips for cell culture, molecular biology, and liquid chromatography!
FDA Lists Bio-Rad’s CFX96 Dx Real-Time PCR System for IVD Testing
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its CFX96 Dx Real-Time PCR System has been listed with the U.S. Food and Drug Administration (FDA) for IVD testing and may be used to help in the diagnosis of COVID-19.